Córdova-Pluma VH, Vega-López CA, Alarcón-Sotelo A, Riancho-Guzmán JA, Almeida-Navarro JS, Salinas-Lezama E

Language: Spanish
References: 23
Page: 540-547
PDF size: 484.16 Kb.

ABSTRACT

Kikuchi-Fujimoto disease is a rare, self-limiting disease of unknown etiology, manifested by lymphadenopathy, fever and less specific symptoms such as nocturnal diaphoresis, weight loss, headache, fatigue, nausea and arthralgias. The only way to establish the diagnosis is through the histopathological findings, characterized by coagulative necrosis with abundant remains of karyorrhexis in paracortical zones. The treatment is symptomatic, and a differential diagnosis must be made with infectious and neoplastic processes. We present the case of a 37-year-old woman in whom the diagnosis of Kikuchi-Fujimoto disease was integrated, and a review of the literature is made.

REFERENCES

1. Alam H, Omar M, Bait A, et al. Kikuchi disease. J Pak Med Assoc 2015;65(12):1349-1350.

2. Jamal A. Kikuchi Fujimoto disease. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2012:5;63- 66.

3. Lonmore M, Wilkinson I, Turmezei T, Cheung CK. Lumps in the neck: Oxford Handbook of Clinical Medicine, 7th ed. New York: Oxford University Press, 2007;620.

4. Ruaro B, Sulli A, Alessandri E, et al. Kikuchi-Fujimoto’s disease associated with systemic lupus erythematous: difficult case report and literature review. Lupus 2014;23(9):939- 944.

5. Deaver D, Naghashpour M, Sokol L. Kikuchi-Fujimoto disease in the Unites States: Three case reports and review of the literature. Mediterr J Hematol Infect Dis 2014; 6; e2014001, DOI: 10.4084/MJHID.2014.001

6. Ohshima K, Karube K, Hamasaki M, et al. Apoptosis- and cell cycle-as sociated gene expression profiling of histiocytic necrotising lymphadenitis. Eur J Haematol 2004;72(5):322- 329.

7. Ohshima K, Haraoka S, Takahata Y, et al. Interferongamma, inter leukin-18, monokine induced by interferongamma and interferon-gamma-in ducible protein-10 in histiocytic necrotizing lymphadenitis. Leuk Lymphoma 2002;43(5):1115-20.

8. Wilson M, Milne G, Vryonis E. Kikuchi-Fujimoto disease: A rare cause of fever in the returning traveller. Case Reports Med 2014;1:1-4.

9. Yilmaz M, Camei C, Sari I, et al. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto’s disease) mimicking systemic lupus erythematous: a review of two cases. Lupus 2006;15:384-387.

10. Kucukardali Y, Solmazgul E, Kunter E, et al. Kikuchi- Fujimoto disease: analysis of 244 cases. Clin Rheumatol 2007;26:50-54.

11. Duskin-Bitar H, Kivity S, Olchovsky D, et al. Kikuchi-Fujimoto disease. IMAJ 2010;12:617-621.

12. Vu D, Reddy S, Day L, et al. Kikuchi-Fujimoto disease: unusual presentation of rare disease. Clin Pract 2016;6(828):16-17.

13. Paradela S, Lorenzo J, Martinez-Gomez W, Yebra-Pimentel T, et al. Interface dermatitis in skin lesions of Kikuchi Fujimoto’s disease: a histopathological marker of evolution into systemic lupus erythematosus? Lupus 2008;17:1127-1135.

14. Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi- Fujimoto disease: a comprehensive review. Am J Clin Pathol 2004;122:141-152.

15. Kwon S, Kim T, Kim Y, et al. CT findings in Kikuchi disease: analysis of 96 cases. Am J Neurorad 2004;25(6):1099-1102.

16. Esra Ö, Ceren G, Zeynep Ö, et al. Evaluation of peripheral lymphadenopathy with excisional biopsy: six-year experience. Int J Clin Exp Pathol 2015;8(11):15234-15239.

17. Veer V, Lim A, Issing W. Case report. Kikuchi-Fujimoto disease: A case report and literature review. Case Reports in Otolaryngology 2012;1-5.

18. Al-Bishri J. Kikuchi Fujimoto disease. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2012;5:63-66.

19. Deaver D, Horna P, Cualing H, et al. Pathogenesis, diagnosis and management of Kikuchi-Fujimoto disease. Cancer Control 2014;21(4):313-321.

20. Yalcin S, Toprak SK, Erismis B, et al. Management of Kikuchi- Fujimoto disease using glucocorticoid: a case report. Case Rep Med 2011;2011:230840.

21. Chen P, Huang Y, Tang C, et al. Kikuchi-Fujimoto disease: an amazing response to hydroxychloroquine. Eur J Pediatr 2010;169(12):1557-1559.

22. Rezai K, Kuchipudi S, Chundi V, et al. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis 2004;39(12):124-126.

23. Cheng C, Sheng W, Lo Y, et al. Clinical presentations, laboratory results and outcomes of patients with Kikuchi’s disease: emphasis on the association between recurrent Kikuchi’s disease and autoimmune diseases. J Microbiol Immunol Infect 2010;43(5):366-371.